Speaker Profile
Ph.D., CEO, Cancer Commons
Biography
Dr. Clifford Reid has over 30 years of experience in leading start-up and growth companies that commercialize important new technologies. Dr. Reid was the founding CEO of Travera, a spinout of MIT that developed a novel live-cell cancer therapy selection test. Prior to founding Travera, he was the founding Executive Chairman of Genos Research, a consumer genomics company that developed a marketplace for genomics research data. Dr. Reid was the founding Chairman and Chief Executive Officer of Complete Genomics (CGI), a leading developer of whole human genome DNA sequencing technologies. He took the company public (GNOM: NASDAQ) and led it through its acquisition by BGI. Prior to CGI he founded two enterprise software companies, Eloquent (ELOQ: NASDAQ, an internet video company) which was acquired by Open Text, and Verity (VRTY: NASDAQ, an enterprise search engine company) which was ultimately acquired by Hewlett-Packard.Dr. Reid is on the Visiting Committee of the Biological Engineering Department at the Massachusetts Institute of Technology (MIT) and is a member of the MIT Corporation Development Committee. He is a scientific advisor to NGD, a bacterial genomics company. He earned a BS in Physics from MIT, an MBA from the Harvard Business School, and a PhD in Management Science and Engineering from Stanford University.
AI and Data Sciences Showcase:
Cancer Commons
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
